Kanika Shanker
Pediatric Endocrinology · Morristown, NJNPI 1265775332
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.3%), consulting fees and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Endo Pharmaceuticals Inc. at 41.4% of the total. Reporting peaked in 2020 at $1,376 and has fallen 85.6% since, to $198 in 2025.
Across 97 payments — averaging $31.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endo Pharmaceuticals Inc.$1K
- Novo Nordisk$391
- AbbVie$176
- Abbott$157
- Valeritas, Inc.$142
- Dexcom, Inc.$110
- plus $811 from 24 others
Across 10 payments — averaging $3689.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mannkind Corporation$37K
What the payments were for
- Consulting fees$1,26541%
- Travel & lodging$853%
- Food & beverage$1,59652%
- Education$1073%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endo Pharmaceuticals Inc. | 1 | $1,265 |
| Novo Nordisk | 22 | $391 |
| AbbVie | 5 | $176 |
| Abbott | 5 | $157 |
| Valeritas, Inc. | 14 | $142 |
| Dexcom, Inc. | 6 | $110 |
| Mannkind Corporation | 1 | $85 |
| Insulet Corporation | 4 | $75 |
| Medtronic(2 entities) | 3 | $69 |
| Ferring Pharmaceuticals Inc. | 4 | $55 |
| Pfizer | 4 | $54 |
| Lilly USA, LLC | 4 | $52 |
| Sanofi-aventis U.S. LLC | 3 | $44 |
| Tandem Diabetes Care, Inc. | 2 | $43 |
| Ascendis Pharma Endocrinology Inc | 2 | $40 |
| AstraZeneca(2 entities) | 2 | $38 |
| Tolmar, Inc. | 2 | $31 |
| Soleno Therapeutics, Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $25 |
| BETA Bionics, Inc. | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $19 |
| Sequel Med Tech, LLC | 1 | $19 |
| Shire North American Group Inc | 1 | $17 |
| Biomarin Pharmaceutical Inc. | 1 | $16 |
| Eton Pharmaceuticals, Inc. | 1 | $16 |
| Tolmar Pharmaceuticals, Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Radius Health, Inc. | 1 | $13 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUPPRELIN$1,265
- Sogroya$120
- Lupron Depot$114
How this compares
$3,052 in reported general payments places this provider in the 70th percentile of 59 pediatric endocrinology providers in New Jersey.
Other pediatric endocrinology in Morristown
- Lawrence SilvermanMorristown$492K
- Barbara CerameMorristown$5K
- Daisy ChinMorristown$1K
- Mansi KanhereMorristown$791
- Melissa WooMorristown$781
- Aditi KhokharMorristown$543
- Harold StarkmanMorristown$263
- Tejal PatelMorristown$146
- Ahmed KhattabNew Brunswick$70K
- Ian MarshallNew Brunswick$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.